OMECAMTIV MECARBIL TABLET
Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core,...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
23.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are tablet formulations comprising a core comprising omecamtiv mecarbil, a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable hydrate of a pharmaceutically acceptable salt thereof; a filler; a binder; a glidant; and a lubricant; and a film coating on the core, the film coating comprising a modified-release polymer and a pore former. Also provided is a process for making a tablet formulation and a method of treating cardiovascular conditions, such as heart failure, using the tablet formulation. |
---|---|
Bibliography: | Application Number: US202117798531 |